Takeda to submit data for pioglitazone containing medicines including ACTOS

Takeda Pharmaceutical Company Limited announced the completion of the post-marketing commitment and submissions of data from a 10-year epidemiology study to regulatory authorities including the United States Food and Drug Administration, the European Medicines Agency and the Japanese Pharmaceuticals and Medical Devices Agency for pioglitazone containing medicines, including ACTOS (pioglitazone HCl).
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Diabetes Oncology ACTOS Latest News pioglitazone pioglitazone HCl regulatory bodies takeda Source Type: news